Intelligent Bio Solutions (INBS) Other financing activities (2020 - 2023)

Intelligent Bio Solutions (INBS) recorded quarterly Other financing activities of $54187.0 in Q2 2023, up 254.42% quarter-over-quarter from -$35091.0 in Q1 2023.

Intelligent Bio Solutions (INBS) Other financing activities (2020 - 2023) Analysis & Trends

Intelligent Bio Solutions' Other financing activities history runs 3 years deep, the most recent figure standing at $54187.0 for Q2 2023.

  • In Q2 2023, Other financing activities changed N/A year-over-year to $54187.0; the TTM figure through Jun 2023 stood at -$287483.0 (changed N/A YoY), while the FY2023 annual figure was $518914.0, changed N/A from the prior year.
  • Other financing activities was $54187.0 for Q2 2023 at Intelligent Bio Solutions, up from -$35091.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $54187.0 in Q2 2023 to a low of -$306579.0 in Q4 2022.
  • Historically, Other financing activities has averaged -$109273.8 across 3 years, with a median of -$92351.5 in 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Intelligent Bio Solutions 12.67 Mn 11.47 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 54,187.00
Jun 30, 2023 54,187.00
Mar 31, 2023 -35,091.00
Mar 31, 2023 -35,091.00
Dec 31, 2022 -306,579.00
Dec 31, 2022 -306,579.00
Dec 31, 2020 -149,612.00
Dec 31, 2020 -149,612.00